PETRONI, MARIA LETIZIA
 Distribuzione geografica
Continente #
AS - Asia 5.787
NA - Nord America 5.600
EU - Europa 3.693
SA - Sud America 379
AF - Africa 293
OC - Oceania 7
Totale 15.759
Nazione #
US - Stati Uniti d'America 5.480
SG - Singapore 1.633
CN - Cina 1.436
VN - Vietnam 1.275
IT - Italia 1.179
GB - Regno Unito 579
HK - Hong Kong 456
DE - Germania 389
BR - Brasile 284
FR - Francia 279
IN - India 253
SE - Svezia 250
NL - Olanda 237
KR - Corea 216
RU - Federazione Russa 180
IE - Irlanda 121
ZA - Sudafrica 112
JP - Giappone 109
FI - Finlandia 96
BD - Bangladesh 81
BG - Bulgaria 67
CA - Canada 64
SC - Seychelles 59
AT - Austria 58
CI - Costa d'Avorio 57
PH - Filippine 54
UA - Ucraina 54
ID - Indonesia 45
EE - Estonia 39
AR - Argentina 34
IQ - Iraq 33
MX - Messico 33
PL - Polonia 33
TR - Turchia 32
TH - Thailandia 30
ES - Italia 26
CH - Svizzera 23
TW - Taiwan 22
JO - Giordania 20
PK - Pakistan 20
BE - Belgio 19
EC - Ecuador 19
CL - Cile 15
NG - Nigeria 15
SA - Arabia Saudita 14
EG - Egitto 12
UZ - Uzbekistan 12
GR - Grecia 11
CO - Colombia 9
TG - Togo 9
LT - Lituania 8
RO - Romania 8
CZ - Repubblica Ceca 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
DZ - Algeria 6
MY - Malesia 6
YE - Yemen 6
AU - Australia 5
NP - Nepal 5
PE - Perù 5
HN - Honduras 4
IR - Iran 4
MA - Marocco 4
NO - Norvegia 4
TN - Tunisia 4
AZ - Azerbaigian 3
BO - Bolivia 3
LY - Libia 3
UY - Uruguay 3
AO - Angola 2
CR - Costa Rica 2
GT - Guatemala 2
IL - Israele 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
ME - Montenegro 1
Totale 15.742
Città #
Singapore 1.104
Ashburn 700
Southend 454
Fairfield 434
Hong Kong 428
Hefei 387
Ho Chi Minh City 323
San Jose 291
Santa Clara 287
Hanoi 281
Seattle 232
Woodbridge 226
Bologna 222
Chandler 202
Seoul 202
Dallas 197
Houston 193
Beijing 163
Wilmington 158
Cambridge 153
Princeton 143
Los Angeles 141
Boardman 136
Dublin 121
Lauterbourg 118
Ann Arbor 97
New York 97
Milan 96
Council Bluffs 88
Tokyo 87
Helsinki 72
Turin 70
Sofia 67
Rome 66
Dong Ket 58
Abidjan 57
Buffalo 54
Johannesburg 54
Westminster 52
Frankfurt am Main 50
Redondo Beach 46
Nanjing 42
Da Nang 41
Bengaluru 40
Vienna 40
Haiphong 39
São Paulo 38
Berlin 32
Shanghai 29
London 28
San Diego 26
Guangzhou 25
Redmond 25
Rimini 25
Munich 24
Saint Petersburg 24
Phoenix 23
Shenyang 23
Falkenstein 22
Jacksonville 22
Jakarta 22
Naples 22
Jinan 21
Amsterdam 20
Clifton 20
Des Moines 20
Piscataway 20
San Francisco 20
Atlanta 19
Brussels 19
Montreal 19
Senigallia 19
Biên Hòa 18
Dearborn 18
Denver 18
Orem 18
Amman 17
Düsseldorf 17
Toronto 17
Warsaw 17
Chicago 16
Medford 16
Nuremberg 16
The Dalles 16
Abeokuta 15
Olalla 15
Padova 15
Tongling 15
Zhengzhou 15
Florence 14
Lappeenranta 14
Bari 13
Cesena 13
Genoa 13
Tân Tiến 13
Brooklyn 12
Changsha 12
Hebei 12
Hải Dương 12
Istanbul 12
Totale 9.635
Nome #
The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review 287
L’assistenza al paziente grande obeso con disabilita’ 262
An all-natural, very low-calorie ketogenic diet (VLCKD) protocol has similar efficacy and safety to commercial meal replacements (whole or partial) in inducing weight loss: results from a prospective, controlled, 4-arm pragmatic trial (KOBE trial) 256
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 242
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis 235
Pulsed Electromagnetic Field (PEMF) stimulation as an adjunct to exercise: a brief review 233
Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential 228
Dietary habits and neurological features of Parkinson's disease patients: Implications for practice 225
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 222
Management of non-alcoholic fatty liver disease 216
Dietary habits in Parkinson's disease: Adherence to Mediterranean diet 210
Analysis of sedentary behaviors, eating habits, and psychological well-being in Italian adolescents 201
Promoting weight loss and psychological well-being in patients with obesity: A sequential combination of behavioural lifestyle intervention and well-being therapy 200
Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy 200
Data architecture framework for improving consumer awareness in food shopping experience 200
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting 198
La riabilitazione in ambito metabolico 195
Psychological distress in morbid obesity in relation to weight history 187
Stress Hyperglycemia and Complications Following Traumatic Injuries in Individuals With/Without Diabetes: The Case of Orthopedic Surgery 178
Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit 177
Combination of GLP-1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study 177
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 176
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update 175
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 174
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 168
Weight loss expectations in obese patients and treatment attrition: an observational multicenter study 167
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations 167
Dati preliminari sullo studio della sintomatologia ortoressica tra pazienti diabetici affetti da epatopatia. 166
Metformin and the Liver: Unlocking the Full Therapeutic Potential 166
Gliomi, neuroglioblastomi e dieta chetogenica negli adulti: una overview di revisioni sistematiche 164
Weight Loss Expectations and Attrition in Treatment-Seeking Obese Women 163
Searching food during the night: the role of video-polysomnography in the characterization of the night eating syndrome 163
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? 162
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 161
Long-term treatment of severe obesity: are lifestyle interventions still an option? 160
Fatty liver in pregnancy: a narrative review of two distinct conditions 159
Effects of an intensive inpatient rehabilitation program in elderly patients with obesity 157
Clinical and psychological correlates of health-related quality of life in obese patients 156
Expected benefits and motivation to weight loss in relation to treatment outcomes in group-based cognitive-behavior therapy of obesity 156
Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls 155
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity 153
The Role of Psychological Well-Being in Weight Loss: New Insights from a Comprehensive Lifestyle Intervention 153
Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over? 152
Personality, attrition and weight loss in treatment seeking women with obesity 151
Prevention and Treatment of Sarcopenic Obesity in Women 151
Weight management, psychological distress and binge eating in obesity. A reappraisal of the problem 150
The effect of lutein on eye and extra-eye health 148
Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: Results of a double blind, randomised clinical trial in morbidly obese females 148
Maternal PKU: Defining phenylalanine tolerance and its variation during pregnancy, according to genetic background 148
Motivational interviewing adapted to group setting for the treatment of relapse in the behavioral therapy of obesity. A clinical audit 144
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 143
Obesity and Eating Disorders. Indications for the different levels of care. An Italian Expert Consensus Document Documento di Consensus. Obesità e Disturbi dell’Alimentazione Indicazioni per i diversi livelli di trattamento a,b,c,d,e [Obesity and Eating Disorders. Indications for the different levels of care. An Italian Expert Consensus Document] 141
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 138
Effect of pulsed electromagnetic fields (PEMFs) on oxygen saturation during a constant-load exercise in overweight people 138
Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver? 135
Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet 133
Chronic Care Models for Obesity Management 133
Rehabilitation in obesity with comorbidities: A consensus document from experts of the Italian Society of Physical and Rehabilitation Medicine (SIMFER), the Italian Society of Obesity (SIO) and the Italian Society of Eating Disorders (SISDCA) 132
Obesity and NAFLD: Same problem? 132
Gait analysis in anorexia and bulimia nervosa 130
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 130
The treatment of diabetes in advanced liver disease: change of a paradigm 128
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 128
Weight cycling and cardiovascular risk factors in obesity 128
Development and application of a simple and powerful tool for nutrition and lifestyle education for the Italian general population by general practitioners and family paediatricians 127
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 125
Long-term mortality in a cohort of severely obese persons in Italy 122
TECNOB study: Ad interim results of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes 119
Principles and protocols in Nutritional Rehabilitation 119
Binge eating disorder in obesity: comparison of different therapeutic strategies 118
Effect of physical exercise on postural control in diabetic subjects 117
Body composition in Parkinson's disease 116
Hospitalization rates and cost in severe or complicated obesity: An Italian cohort study 116
Ketogenic diet as rescue therapy to access transplantation in obese and advanced stage IV-CKD patients: a case report and literature review 115
NASH: A glance at the landscape of pharmacological treatment 114
Prevalence and burden of obesity in Rehabilitation Units in Italy: a survey 113
Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study 113
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease 113
Undernutrition, risk of malnutrition and obesity in gastroenterological patients: A multicenter study 112
Promoting positive mental health for sustainable eating behaviors: the PROMISE study in patients with obesity 112
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 110
Sporadic mutations in melanocortin receptor 3 in morbid obese individuals 109
Risk of suicide and bariatric surgery 108
Balance in patients with anorexia and bulimia nervosa 106
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients 106
Weight loss and clinical characteristics of young adults patients seeking treatment at medical centers: Data from the QUOVADIS Study 104
TECNOB: study design of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes 103
Progetto DUSE: analisi preliminare dei comportamenti sedentari, delle abitudini alimentari e del benessere psicologico negli adolescenti italiani 102
Validation of food frequency questionnaire for assessing dietary macronutrients and calcium intake in Italian children and adolescents 102
La prevenzione dell'obesità genetica 101
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 99
Relationship Between Physical Activity and Autonomic Responses in Adults with Type 2 Diabetes 98
'Effect of exercise training on postural control in people with diabetes 97
Exercise-induced changes in postural stability among patients with diabetes 96
Effects of physical exercise on autonomic control in diabetic patients. 96
RANK-RANKL-OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives 94
Impact of exercise training on postural control in people with diabetes. 91
Prevalence of orthorexic traits in type 2 diabetes mellitus: at the crossroads between nutritional counseling and eating disorders 90
Ketogenic enteral nutrition for weight loss: a word of warning 84
Obesità e farmaci 81
Totale 14.859
Categoria #
all - tutte 45.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021204 0 0 0 0 0 0 0 0 0 0 0 204
2021/20221.139 67 51 62 28 118 74 16 132 56 45 274 216
2022/20231.296 105 143 59 143 94 107 62 87 226 50 133 87
2023/2024553 33 70 38 43 51 115 24 54 14 31 32 48
2024/20252.911 94 291 227 249 418 137 181 118 104 303 195 594
2025/20267.552 599 783 744 688 626 362 856 314 1.336 554 474 216
Totale 16.087